Phase 4
Completed N=201
Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia
Source: ClinicalTrials.gov NCT00576316 ↗Enrolled (actual)
201
Serious AEs
—
Results posted
Dec 2009
Primary outcomePrimary: Change in Satisfaction With Asthma Treatment Questionnaire (SATQ) Scores From Baseline to the Mean of 3 Months and 6 Months After Patient Was Initially Treated With SMART — 0.37 Scores on a scale
Summary
The purpose of the study is to evaluate the satisfaction level of patients using the Symbicort SMART approach for their asthma management.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Satisfaction With Asthma Treatment Questionnaire (SATQ) Scores From Baseline to the Mean of 3 Months and 6 Months After Patient Was Initially Treated With SMART |
0.37 | — |
| SECONDARY Changes in Asthma Control Questionnaire (ACQ-5) Score From Baseline to the Mean of 3 Months and 6 Months After Patient Was Initially Treated With SMART |
-0.97 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosis of asthma for past 6 months and treated with inhaled glucocorticosteroids for at least 3 months.
- Patients who asthma is classified as uncontrolled or partially controlled as defined by GINA 2006 guidelines.
Exclusion Criteria
- Patients already on Symbicort SMART treatment.
- Patients who has respiratory tract infection 30 days before study enrolment.
Data sourced from ClinicalTrials.gov (NCT00576316). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.